OVS (OVS) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
24 Jun, 2026Executive summary
Achieved record first-half 2025 results with net sales of €792.9 million, up 4.1% year-over-year, driven by strong organic growth, women's apparel, beauty, and the first-time consolidation of Goldenpoint.
Adjusted EBITDA rose to €101.7 million (+14.3%), with margin improving to 12.8%; adjusted net profit increased by 32% to €46 million.
Goldenpoint contributed €15 million in sales since July consolidation, accelerating growth in a high-margin segment.
Outperformed the Italian clothing market, which declined by about 1% year-over-year.
August and September saw double-digit like-for-like sales growth, with new Upim store formats exceeding expectations.
Financial highlights
Net sales: €792.9 million (+4.1% year-over-year); adjusted EBITDA: €101.7 million (+14.3%), margin 12.8%; adjusted net profit: €45.6 million (+31.7%).
Gross margin improved to 60.7% (from 59.6%); adjusted EBIT: €69.2 million (+20.8%), margin 8.7%.
Adjusted net financial debt: €293.6 million, leverage ratio 1.41x; average leverage over last 12 months: 1.26x.
Working capital stable; inventory elevated at €550.6 million due to Suez Canal disruption and Goldenpoint acquisition.
Treasury shares as of September 2025: 4.297% of share capital.
Outlook and guidance
Management confirms full-year growth expectations, with mid-single-digit revenue growth and €70 million free cash flow forecasted.
Goldenpoint expected to contribute €60 million in H2 sales; free cash flow impact neutral.
CapEx guidance for the year is €70–75 million, with a sharper drop expected from 2026.
Gross margin for the full year expected to remain above last year, with some benefit from favorable FX hedging in 2026.
Recent store openings and new formats support a positive outlook for the remainder of the year.
Latest events from OVS
- Q3 2024 saw double-digit sales and EBITDA growth, with robust outlook and enhanced shareholder returns.OVS
Q3 20258 Jul 2026 - Sales and margins rose in H1 2024, with strong outlook and expanded buyback.OVS
Q2 202524 Jun 2026 - Net sales up 12.1% and organic EBITDA up 27.1%, with improved leverage and strong outlook.OVS
Q1 202718 Jun 2026 - Record sales, profit, and cash flow growth drive a 27% dividend hike and strong 2026 outlook.OVS
Q4 202617 Apr 2026 - Q1 sales and margins rose, with strong brand momentum and a positive outlook for 2024.OVS
Q1 20253 Feb 2026 - Sales up 6.2%, margins and cash flow improved, with higher dividend and buyback ahead.OVS
Q4 202523 Dec 2025 - Sales and EBITDA up, leverage improved, and outlook remains positive for year-end.OVS
Q3 202618 Dec 2025 - Q1 sales grew 0.6% to €354.4m; Goldenpoint synergies and Q2 momentum support a positive outlook.OVS
Q1 202614 Nov 2025